Skip to content

    Cancer Health Center

    Font Size

    Plasma Cell Neoplasms (Including Multiple Myeloma) Treatment (PDQ®): Treatment - Health Professional Information [NCI] - General Information About Plasma Cell Neoplasms

    Table 1. Clinical Presentation of Plasma Cell Neoplasms continued...

    These initial studies should be compared with subsequent values at a later time, when it is necessary to decide whether the disease is stable or progressive, responding to treatment, or getting worse.

    As mentioned before, the major challenge is to separate the stable, asymptomatic group of patients who do not require treatment from patients with progressive, symptomatic myeloma who should be treated immediately.[6,7]

    Monoclonal Gammopathy of Undetermined Significance (MGUS)

    Patients with MGUS have an M protein in the serum without findings of multiple myeloma, macroglobulinemia, amyloidosis, or lymphoma and have fewer than 10% of plasma cells in the bone marrow.[2,17,18,19] Patients with smoldering myeloma have similar characteristics but may have more than 10% of plasma cells in the bone marrow.

    These types of patients are asymptomatic and should not be treated. They must, however, be followed carefully since about 1% to 2% of MGUS patients per year will progress to develop myeloma (most commonly), amyloidosis, lymphoma, or chronic lymphocytic leukemia and may then require therapy.[19,20,21]

    Virtually all cases of multiple myeloma are preceded by a gradually rising level of MGUS.[22,23,24]

    Risk factors that predict disease progression include the following:

    • An abnormal serum-free light chain ratio.
    • Non-IgG class MGUS.
    • A high serum-M protein level (≥15 g/L).[25]

    Isolated Plasmacytoma of Bone

    The patient has an isolated plasmacytoma of the bone if the following are found:

    • A solitary lytic lesion of plasma cells on skeletal survey in an otherwise asymptomatic patient.
    • A bone marrow examination from an uninvolved site contains less than 10% plasma cells.[26,27,28]

    When clinically indicated, MRI may reveal unsuspected bony lesions that were undetected on standard radiographs. MRI scans of the total spine may identify other bony lesions.[29]

    Extramedullary Plasmacytoma

    A patient has extramedullary plasmacytoma if the following are found:

    • Isolated plasma-cell tumors of soft tissues, most commonly occurring in the tonsils, nasopharynx, or paranasal sinuses.
    • Negative findings on skeletal x-rays and bone marrow biopsy.[30,31,32]

    Multiple Myeloma

    Multiple myeloma is a systemic malignancy of plasma cells that typically involves multiple sites within the bone marrow and secretes all or part of a monoclonal antibody.

    1 | 2 | 3
    Next Article:

    Today on WebMD

    man holding lung xray
    What you need to know.
    stem cells
    How they work for blood cancers.
    woman wearing pink ribbon
    Separate fact from fiction.
    Colorectal cancer cells
    Symptoms, screening tests, and more.
    Jennifer Goodman Linn self-portrait
    what is your cancer risk
    colorectal cancer treatment advances
    breast cancer overview slideshow
    prostate cancer overview
    lung cancer overview slideshow
    ovarian cancer overview slideshow
    Actor Michael Douglas